Insider Selling: Nukkleus (NASDAQ:NUKK) Insider Sells 55,604 Shares of Stock

Nukkleus Inc. (NASDAQ:NUKK) insider Anastasiia Kotaieva sold 55,604 shares of the stock in a transaction dated Friday, December 26th. The stock was sold at an average price of $4.26, for a total transaction of $236,873.04. Following the sale, the insider owned 1,149,989 shares of the company’s stock, valued at $4,898,953.14. This trade represents a 4.61% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Anastasiia Kotaieva also recently made the following trade(s):

• On Wednesday, December 24th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The stock was sold at an average price of $4.49, for a total transaction of $249,661.96.
• On Tuesday, December 23rd, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The stock was sold at an average price of $4.57, for a total transaction of $319,900.00.
• On Monday, December 22nd, Anastasiia Kotaieva sold 30,000 shares of Nukkleus stock. The shares were sold at an average price of $4.41, for a total transaction of $132,300.00.
• On Friday, December 19th, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The stock was sold at an average price of $4.53, for a total value of $317,100.00.
• On Thursday, December 18th, Anastasiia Kotaieva sold 38,744 shares of Nukkleus stock. The shares were sold at an average price of $4.72, for a total value of $182,871.68.

Nukkleus Stock Up 3.5%

NUKK traded up $0.14 during trading on Wednesday, hitting $4.17. The company’s stock had a trading volume of 355,807 shares, compared to its average volume of 1,721,200. The stock has a market capitalization of $69.43 million, a price-to-earnings ratio of 0.25 and a beta of -6.75. The firm’s 50 day moving average price is $5.68 and its two-hundred day moving average price is $6.79. Nukkleus Inc. has a 12 month low of $3.31 and a 12 month high of $40.98.

Hedge Funds Weigh In On Nukkleus

Large investors have recently added to or reduced their stakes in the company. Ausdal Financial Partners Inc. acquired a new position in shares of Nukkleus during the 3rd quarter worth about $105,000. UBS Group AG increased its stake in Nukkleus by 23.3% during the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after acquiring an additional 15,223 shares during the period. Finally, BNP Paribas Financial Markets acquired a new position in Nukkleus in the second quarter valued at about $56,000. Institutional investors own 12.47% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently weighed in on NUKK. Weiss Ratings reissued a “sell (d+)” rating on shares of Nukkleus in a research note on Wednesday, December 24th. Wall Street Zen upgraded Nukkleus from a “sell” rating to a “hold” rating in a report on Sunday, November 23rd. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.

Nukkleus Company Profile

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.